Phibro Animal Health Corp (PAHC)
18.48
+0.07
(+0.38%)
USD |
NASDAQ |
May 23, 16:00
18.48
0.00 (0.00%)
After-Hours: 20:00
Phibro Animal Health Enterprise Value: 1.133B for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 1.133B |
| May 21, 2024 | 1.131B |
| May 20, 2024 | 1.125B |
| May 17, 2024 | 1.132B |
| May 16, 2024 | 1.115B |
| May 15, 2024 | 1.126B |
| May 14, 2024 | 1.125B |
| May 13, 2024 | 1.121B |
| May 10, 2024 | 1.098B |
| May 09, 2024 | 1.104B |
| May 08, 2024 | 1.083B |
| May 07, 2024 | 1.066B |
| May 06, 2024 | 1.053B |
| May 03, 2024 | 1.078B |
| May 02, 2024 | 1.066B |
| May 01, 2024 | 1.049B |
| April 30, 2024 | 1.063B |
| April 29, 2024 | 1.067B |
| April 26, 2024 | 902.68M |
| April 25, 2024 | 890.94M |
| April 24, 2024 | 895.80M |
| April 23, 2024 | 938.32M |
| April 22, 2024 | 915.64M |
| April 19, 2024 | 925.77M |
| April 18, 2024 | 915.24M |
| Date | Value |
|---|---|
| April 17, 2024 | 908.35M |
| April 16, 2024 | 913.21M |
| April 15, 2024 | 922.12M |
| April 12, 2024 | 918.07M |
| April 11, 2024 | 917.26M |
| April 10, 2024 | 922.93M |
| April 09, 2024 | 918.48M |
| April 08, 2024 | 908.76M |
| April 05, 2024 | 905.92M |
| April 04, 2024 | 909.57M |
| April 03, 2024 | 910.78M |
| April 02, 2024 | 896.20M |
| April 01, 2024 | 897.82M |
| March 31, 2024 | 910.78M |
| March 28, 2024 | 906.12M |
| March 27, 2024 | 911.38M |
| March 26, 2024 | 902.47M |
| March 25, 2024 | 890.73M |
| March 22, 2024 | 872.09M |
| March 21, 2024 | 879.79M |
| March 20, 2024 | 887.08M |
| March 19, 2024 | 886.67M |
| March 18, 2024 | 887.89M |
| March 15, 2024 | 882.22M |
| March 14, 2024 | 872.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
780.14M
Minimum
Nov 30 2023
1.566B
Maximum
Aug 20 2019
1.124B
Average
1.110B
Median
Jun 02 2022
Enterprise Value Benchmarks
| Stryker Corp | 138.24B |
| Haemonetics Corp | 5.209B |
| SINTX Technologies Inc | 5.833M |
| Perspective Therapeutics Inc | 748.78M |
| Electromed Inc | 129.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 8.405M |
| Revenue (Quarterly) | 263.22M |
| Total Expenses (Quarterly) | 243.30M |
| EPS Diluted (Quarterly) | 0.21 |
| Gross Profit Margin (Quarterly) | 30.24% |
| Profit Margin (Quarterly) | 3.19% |
| Earnings Yield | 1.79% |
| Operating Earnings Yield | 7.84% |
| Normalized Earnings Yield | 3.154 |